Literature DB >> 15477094

Expression and purification of his-tagged rat peroxisomal acyl-CoA oxidase I wild-type and E421 mutant proteins.

Jia Zeng1, Ding Li.   

Abstract

Rat peroxisomal acyl-CoA oxidase I is a key enzyme for the beta-oxidation of fatty acids, and the deficiency of this enzyme in patients has been previously reported. We cloned the gene of rat peroxisomal acyl-CoA oxidase I into a bacterial expression vector pLM1 with six continuous histidine codons attached to the 5' end of the gene. The cloned gene was overexpressed in Escherichia coli and the soluble protein was purified with a nickel HiTrap chelating metal-affinity column in 90% yield to apparent homogeneity. The specific activity of the purified His-tagged rat peroxisomal acyl-CoA oxidase I was 1.5 micromol/min/mg. It has been proposed that Glu421 is a catalytic residue responsible for deprotonation of alpha-proton of acyl-CoA substrate. We constructed four mutant expression plasmids of the enzyme, pACO(E421D), pACO(E421A), pACO(E421Q), and pACO(E421G) using site-directed mutagenesis. Mutant proteins were overexpressed in E. coli and purified with a nickel metal-affinity column. Kinetic studies of wild-type and mutant proteins were carried out, and the result confirmed that Glu421 is a catalytic residue of rat peroxisomal acyl-CoA oxidase I. Our overexpression in E. coli and one-step purification of the highly active N-terminal His-tagged rat peroxisomal acyl-CoA oxidase I greatly facilitated our further investigation of this enzyme, and our result from site-directed mutagenesis increased our understanding of the mechanism for the reaction catalyzed by peroxisomal acyl-CoA oxidase I.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477094     DOI: 10.1016/j.pep.2004.08.013

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis.

Authors:  Jonathan P Gumucio; Austin H Qasawa; Patrick J Ferrara; Afshan N Malik; Katsuhiko Funai; Brian McDonagh; Christopher L Mendias
Journal:  FASEB J       Date:  2019-04-02       Impact factor: 5.191

2.  Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet.

Authors:  Jia Zeng; Senwen Deng; Yiping Wang; Ping Li; Lian Tang; Yefeng Pang
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

3.  SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer.

Authors:  Xiu-Fei Chen; Meng-Xin Tian; Ren-Qiang Sun; Meng-Li Zhang; Li-Sha Zhou; Lei Jin; Lei-Lei Chen; Wen-Jie Zhou; Kun-Long Duan; Yu-Jia Chen; Chao Gao; Zhou-Li Cheng; Fang Wang; Jin-Ye Zhang; Yi-Ping Sun; Hong-Xiu Yu; Yu-Zheng Zhao; Yi Yang; Wei-Ren Liu; Ying-Hong Shi; Yue Xiong; Kun-Liang Guan; Dan Ye
Journal:  EMBO Rep       Date:  2018-02-28       Impact factor: 8.807

Review 4.  Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.

Authors:  Surinder Kumar; David B Lombard
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04-11       Impact factor: 8.250

5.  ACOX1 destabilizes p73 to suppress intrinsic apoptosis pathway and regulates sensitivity to doxorubicin in lymphoma cells.

Authors:  Fei-Meng Zheng; Wang-Bing Chen; Tao Qin; Li-Na Lv; Bi Feng; Yan-Ling Lu; Zuo-Quan Li; Xiao-Chao Wang; Li-Ju Tao; Hong-Wen Li; Shu-You Li
Journal:  BMB Rep       Date:  2019-09       Impact factor: 4.778

Review 6.  Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.

Authors:  Francesco Fiorentino; Carola Castiello; Antonello Mai; Dante Rotili
Journal:  J Med Chem       Date:  2022-07-08       Impact factor: 8.039

7.  Label-Free Proteomics of the Fetal Pancreas Identifies Deficits in the Peroxisome in Rats with Intrauterine Growth Restriction.

Authors:  Xiaomei Liu; Yanyan Guo; Jun Wang; Linlin Gao; Caixia Liu
Journal:  Oxid Med Cell Longev       Date:  2019-11-03       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.